Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany
- PMID: 35357770
- DOI: 10.1111/jvh.13680
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany
Abstract
In 2014, an analysis was conducted to evaluate the hepatitis C virus (HCV) epidemiology and disease burden in Germany. Since then, there have been considerable developments in HCV management such as the implementation of direct acting antivirals. The aim of this analysis was to assess the recent data available for Germany, establish an updated 2020 HCV prevalence and cascade of care and evaluate the impact of what-if scenarios on the future burden of disease using modelling analysis. A dynamic Markov model was used to forecast the HCV disease burden in Germany. Model inputs were retrieved through literature review, unpublished sources and expert input. Next, three "what-if" scenarios were developed to evaluate the status quo, COVID-19 pandemic, and steps needed to achieve the WHO targets for elimination. At the beginning of 2020, there were 189,000 (95% UI: 76,700-295,000) viremic infections in Germany, a decline of more than 85,000 viremic infections since 2012. Annual treatment starts went down since 2015. Compared with 2019, the COVID-19 pandemic resulted in a further 11% decline in 2020. If this continues for two years, it could result in 110 excess HCC cases and 200 excess liver related deaths by 2030. To achieve the WHO targets, 81,200 people need to be diagnosed, with 118,600 initiated on treatment by 2030. This could also avert 1,020 deaths and 720 HCC cases between 2021 and 2030. Germany has made strides towards HCV elimination, but more efforts are needed to achieve the WHO targets by 2030.
Keywords: COVID-19; Germany; elimination; hepatitis C virus.
© 2022 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Similar articles
-
Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.PLoS One. 2022 Aug 12;17(8):e0272518. doi: 10.1371/journal.pone.0272518. eCollection 2022. PLoS One. 2022. PMID: 35960770 Free PMC article.
-
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.Swiss Med Wkly. 2019 Jan 23;149:w14694. doi: 10.4414/smw.2019.14694. eCollection 2019 Jan 14. Swiss Med Wkly. 2019. PMID: 30673118
-
Securing wider EU commitment to the elimination of hepatitis C virus.Liver Int. 2023 Feb;43(2):276-291. doi: 10.1111/liv.15446. Epub 2022 Dec 14. Liver Int. 2023. PMID: 36196744 Review.
-
Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis.PLoS One. 2022 May 12;17(5):e0267853. doi: 10.1371/journal.pone.0267853. eCollection 2022. PLoS One. 2022. PMID: 35551326 Free PMC article.
-
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.Lancet Gastroenterol Hepatol. 2022 May;7(5):396-415. doi: 10.1016/S2468-1253(21)00472-6. Epub 2022 Feb 16. Lancet Gastroenterol Hepatol. 2022. PMID: 35180382 Review.
Cited by
-
Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.BMC Gastroenterol. 2023 Nov 11;23(1):386. doi: 10.1186/s12876-023-03016-7. BMC Gastroenterol. 2023. PMID: 37951862 Free PMC article.
-
[Strategietreffen: Virushepatitis in Deutschland eliminieren].Z Gastroenterol. 2023 Feb;61(2):198-201. doi: 10.1055/a-1978-9021. Epub 2023 Feb 3. Z Gastroenterol. 2023. PMID: 36736343 Free PMC article. German. No abstract available.
-
Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021.Front Public Health. 2023 May 30;11:1149694. doi: 10.3389/fpubh.2023.1149694. eCollection 2023. Front Public Health. 2023. PMID: 37325322 Free PMC article.
-
Global epidemiology of cirrhosis - aetiology, trends and predictions.Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36977794 Free PMC article. Review.
-
[Hepatitis C in prisons : Treatment and barriers to the elimination goals of the United Nations].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Jan;67(1):36-44. doi: 10.1007/s00103-023-03808-y. Epub 2023 Dec 28. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 38155308 Free PMC article. German.
References
REFERENCES
-
- Wedemeyer H, Duberg AS, Buti M, et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat. 2014;21(Suppl 1):60-89.
-
- Robert Koch Institute. Epidemiological Bulletin 30/31 2020. [Viral Hepatitis B and D as Well as Viral Hepatitis C in 2019]. 23/7/2020 2020.
-
- Razavi H, Waked I, Sarrazin C, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat. 2014;21(Suppl 1):34-59.
-
- SurvStat@RKI 2.0 2020. 2020. https://survstat.rki.de. Accessed 1 October 2020.
-
- Sarrazin C, Zimmermann T, Berg T, et al. Prophylaxis, diagnosis and therapy of hepatitis-C-virus (HCV) infection: the German guidelines on the management of HCV infection - AWMF-Register-No.: 021/012. Z Gastroenterol. 2018;56(7):756-838.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical